Furthermore, dendrobine may contribute to the amelioration of liver damage in MASLD patients by downregulating genes like AKT1 and STAT3, thereby diminishing hepatic lipid accumulation. This evidence concerns the gene STAT3 and metabolic dysfunction-associated steatotic liver disease.